GC3106
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GC3106, covering 2014-12-05 to 2014-12-05. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, and Immunogenicity of GC3106 (Quadrivalent Cell-culture Based Influenza Vaccine) [Phase 1, Phase 2]